● pepmg Research Desk · Peer-reviewed evidence review
What the research says about GHK-Cu
A neutral summary of the peer-reviewed literature on GHK-Cu, a copper-binding tripeptide studied largely in cell, animal, and topical-cosmetic models of skin and tissue repair. Controlled injectable human trials are essentially absent. Research use only.
Preclinical only — Animal or in-vitro studies only — no controlled human trials. This describes the state of the published literature, not a claim that this compound works, is safe, or is for human use. Research use only.
The short version
- GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine complexed with copper) studied largely in cell, animal, and topical-cosmetic models of skin and tissue repair [1][2].
- In these models it stimulated collagen and other matrix synthesis, wound healing, and antioxidant and anti-inflammatory activity [1][2].
- Robust controlled human trials of injectable GHK-Cu are essentially absent; most human-relevant data come from topical cosmetic use [4].
- This page reports what the studies measured. It is not medical advice, an efficacy or safety claim, or dosing guidance. Research use only.
What GHK-Cu is
GHK-Cu is described in the literature as the copper(II) complex of the human tripeptide glycyl-L-histidyl-L-lysine (GHK), a sequence found naturally in human plasma that binds copper with high affinity [2]. Reviews report that GHK levels in serum decline with age [3]. The molecule is studied for tissue remodeling and is widely used as a topical cosmetic ingredient [4]. Material sold by third-party research-chemical vendors, including injectable preparations, is offered for laboratory and research use only.
The published evidence for GHK-Cu is predominantly preclinical, from cell cultures and animal models, together with cosmetic-formulation research [1][4].
What the preclinical research has measured
Preclinical onlyReviews summarize a broad range of laboratory actions attributed to GHK and GHK-Cu, including stimulation of collagen, elastin, and glycosaminoglycan synthesis, support of dermal fibroblasts, promotion of blood-vessel and nerve outgrowth, and antioxidant and anti-inflammatory effects, with wound-healing activity reported across skin, lung, bone, liver, and stomach-lining models [1][2]. A gene-expression review proposed that these diverse actions may reflect GHK's influence on many biochemical pathways at once [1].
Animal studies have examined GHK-Cu in specific injury models: transiently improving graft healing after anterior cruciate ligament reconstruction in rats [5], reducing inflammatory signaling in a mouse model of lipopolysaccharide-induced acute lung injury [6], and accelerating scald-wound healing in mice when delivered in liposomes [7]. A cosmetic-focused review noted that, although cell studies support GHK as an anti-wrinkle ingredient, there is a surprising absence of controlled clinical studies of GHK-Cu and its derivatives, and that skin permeability is a formulation challenge [4].
What the trials report on safety and adverse events
Preclinical onlyThere is little controlled human-trial safety data for GHK-Cu to report, and essentially none for injectable use. The peer-reviewed literature is dominated by cell and animal experiments and by topical cosmetic formulation studies, which are not designed to establish the safety of systemic or injected administration [1][4].
Because human safety for injectable GHK-Cu is not established, nothing here should be read as evidence that it is safe to inject. Topical cosmetic use is a different route and context from the injectable research-chemical products some vendors sell. This is not medical advice; consult a qualified professional and read the studies directly.
How strong is the evidence
Because the GHK-Cu evidence base is predominantly preclinical and topical-cosmetic, with an absence of controlled injectable human trials, it is characterized as preclinical only [1][4]. Preclinical and cosmetic-formulation findings do not establish that injected GHK-Cu works or is safe in humans.
Nothing here is dosing, medical, or safety guidance. Read the studies themselves and consult a qualified professional. This page is a map to the evidence, not a recommendation.
Sources · 7
- Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data.
- The human tri-peptide GHK and tissue remodeling.
- The potential of GHK as an anti-aging peptide.
- Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective.
- Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction.
- The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice.
- GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow any citation to its source and read it yourself. Research use only.